![Robert D. Ciappenelli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert D. Ciappenelli
No open positions remaining
Profile
Robert D.
Ciappenelli served as Vice President-Commercial Operations at Sumitomo Pharma America, Inc. from 2001 to 2012.
He then worked as Global Head-Commercial at Momenta Pharmaceuticals, Inc. from 2016 to 2018.
Currently, he is serving as Chief Strategy Officer at Dicerna Pharmaceuticals, Inc. since 2021.
In terms of education, Mr. Ciappenelli holds an MBA from Harvard Business School and an undergraduate degree from the University of Massachusetts Amherst College of Natural Science.
Former positions of Robert D. Ciappenelli
| Companies | Position | End |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2023 |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2018 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Corporate Officer/Principal | - |
Training of Robert D. Ciappenelli
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
22
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts Amherst College of Natural Science
 University of Massachusetts Amherst College of Natural Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Robert D. Ciappenelli
